A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer

NCT01767857 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

643

Enrollment

INDUSTRY

Sponsor class

Stopped The study crossed the prospective futility boundary of primary endpoint

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Xilonix
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC